Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti-Prostate Stem Cell Antigen Cys-Diabody

Conclusion: Dual-modality imaging using the anti-PSCA cys-diabody resulted in high-contrast immuno-PET/NIRF images of PDX-PDACs, suggesting that this imaging agent might offer both noninvasive whole-body imaging to localize PSCA-positive pancreatic cancer and fluorescence image–guided identification of tumor margins during surgery.

Source: Journal of Nuclear Medicine - September 4, 2018 Category: Nuclear Medicine Authors: Zettlitz, K. A., Tsai, W.-T. K., Knowles, S. M., Kobayashi, N., Donahue, T. R., Reiter, R. E., Wu, A. M. Tags: Basic Source Type: research